According to CRISPR Therapeutics's latest financial reports the company's current revenue (TTM ) is ₹3.03 Billion. a decrease over the revenue in the year 2023 that were of ₹30.80 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.